|
⚲
|
| Keyboard |
| Shih Alvin
✚
|
|
|---|---|
| CIK # | 0001610064 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001610064] | |
| 4 | [0001610064] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shih Alvin | |
| Zevra Therapeutics Inc | |
| Oaktree Acquisition Corp III Life Sciences | |
| Travere Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2025-05-29 | Grant | 30,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2024-05-13 | Grant | 39,200 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2024-01-20 | Grant | 58,800 | $0.00 | |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2016-09-01 | Sell | 8,750 | $16.24 | 142,100 |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2016-06-01 | Sell | 8,750 | $17.75 | 155,312 |
|
Travere Therapeutics Inc RTRX
Employee stock option (right to buy) · derivative
|
2016-05-19 | Grant | 60,000 | $0.00 | |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2016-03-01 | Sell | 8,750 | $14.35 | 125,562 |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2015-12-09 | Sell | 8,750 | $20.83 | 182,262 |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2015-10-06 | Sell | 1,129 | $21.61 | 24,398 |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2015-10-06 | Sell | 2,823 | $20.45 | 57,730 |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2015-10-06 | Sell | 4,798 | $19.58 | 93,945 |
|
Travere Therapeutics Inc RTRX
Employee stock option (right to buy) · derivative
|
2015-07-01 | Grant | 60,000 | $0.00 | |
|
Travere Therapeutics Inc RTRX
Common Stock
|
2015-06-26 | Sell | 27,916 | $32.70 | 912,853 |